U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362173) titled 'Actualities in Procedural Sedation: Remimazolam' on July 04, 2025. Brief Summary: Remimazo... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364383) titled 'Probiotics for Women' on Jan. 06. Brief Summary: Investigation into the effect of probioti... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361770) titled 'Comparative Effect of Instrument Assisted Soft Tissue Mobilization and Cross Fiber Massage ... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361757) titled 'Qualia Perimenopause Efficacy and Tolerability Study: An Open-label 3-Arm Trial' on Jan. 15... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364227) titled 'Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis' on Ja... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362420) titled 'Comparing Myofascial Exercise and Trigger Point Therapy for Non-Specific Low Back Pain' on ... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364019) titled 'The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia' on Jan. 15. B... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361471) titled 'Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differ... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363967) titled 'A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokin... Read More
U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362758) titled 'Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune... Read More